Virtual Library

Start Your Search

Seiji Omura

Author of

  • +

    P3.17 - Treatment of Locoregional Disease - NSCLC (Not CME Accredited Session) (ID 983)

    • Event: WCLC 2018
    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 1
    • Moderators:
    • Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
    • +

      P3.17-10 - Outcome of Surgical Resection for Superior Sulcus Tumor: Experience at a Single Institution. (ID 12807)

      12:00 - 13:30  |  Presenting Author(s): Seiji Omura

      • Abstract
      • Slides


      Superior sulcus tumors are some of the most challenging thoracic malignant disease to treat because of their proximity to vital structures at the thoracic inlet. The aim of this study was to investigate the outcome of surgical treatment for the patients with superior sulcus tumor who underwent surgery in our institution.

      a9ded1e5ce5d75814730bb4caaf49419 Method

      Between 2006 and 2017, 8 patients with non-small cell lung cancer with invasion of the superior sulcus underwent surgical resection, and their clinical and pathological data were retrospectively reviewed. Postoperative complications were defined as events of grade 2 or more according to the Clavien-Dindo classification. Overall survival (OS) rates were compared using a log-rank test and survival curves were plotted using the Kaplan–Meier method.

      4c3880bb027f159e801041b1021e88e8 Result

      Participants comprised 6 men and 2 women, ranging in age from 46 to 76 years (median, 69 years). Median observation period in the survivors was 61.0 months (range, 10-125 months). One patient underwent surgical resection with median sternotomy and posterolateral thoracotomy, and all otherswith posterolateral thoracotomy. One patient underwent combined resection of left innominate vein and chest wall, and all others underwent combined resection of chest wall, respectively. The histologic types were adenocarcinoma, squamous cell carcinoma and large cell carcinoma in 3, 3 and 2 cases, respectively. A complete resection was achieved in seven patients (87.5%), and there was no fatal complication and no postoperative mortality. The 5-year overall survival rate for all the patients were 62.5%.

      8eea62084ca7e541d918e823422bd82e Conclusion

      In our institution, 87.5%of patients with superior sulcus tumor could achieve complete resection. There was no postoperative mortality, and no postoperative complication of grade3 or more. Our result indicated that complete resection could impact the overall survival of the patients with superior sulcus tumor, as well as the patients with lung cancer with chest wall invasion except superior sulcus tumor.


      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.